3//SEC Filing
OcuMension Therapeutics 3
Accession 0000905148-21-000054
CIK 0001314102other
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 8:07 AM ET
Size
13.2 KB
Accession
0000905148-21-000054
Insider Transaction Report
Form 3
Ocumension Therapeutics
10% Owner
Holdings
- 3,010,722
Common Stock, $0.001 par value
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001840315
Filing Metadata
- Form type
- 3
- Filed
- Jan 13, 7:00 PM ET
- Accepted
- Jan 14, 8:07 AM ET
- Size
- 13.2 KB